|
Powered by Cell Signaling Technology |
Site Information |
---|
IkPQRRLsAsRRVGL SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 450013 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: |
Downstream Regulation | |
---|---|
Effects of modification on GATA4: | |
Effects of modification on biological processes: | |
Induce interaction with: |
References | |
---|---|
Ma Y, Wang J, Yu Y, Schwartz RJ (2016) PKG-1α mediates GATA4 transcriptional activity. Cell Signal 28, 585-94
26946174 Curated Info |
|
Moritz A (2007) CST Curation Set: 3608; Year: 2007; Biosample/Treatment: cell line, MKN-45/Su11274; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: 9614, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: 1978
Curated Info |
|
Bouchard MF, Taniguchi H, Viger RS (2005) Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells. Endocrinology 146, 4905-16
16109788 Curated Info |